Hata Hidenori, Uenaka Akiko, Takada Itsuro, Kenjo Akira, Takahashi Minoru, Ono Toshiro, Fujita Teizo, Nakayama Eiichi
Department of Immunology, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan.
Int J Oncol. 2002 May;20(5):1019-25.
We investigated the generation of CD8 cytotoxic T-lymphocytes (CTL) that recognized a dominant pRL1a peptide bound to H-2L(d) molecule on RL male 1 leukemia in spleen cells from RL male 1-bearing syngeneic BALB/c, semiallogeneic CB6F1 and allogeneic B6 mice by repetitive in vitro stimulation with RL male 1 tumor. CD8 T cells in cultures were also analyzed by H-2L(d)/pRL1a tetramer staining. We showed that pRL1a-specific CTL were more efficiently generated in spleen cells from RL male 1-bearing high responder CB6F1 mice than in low responder BALB/c mice, and this correlated well with the occurrence of H-2L(d)/pRL1a tetramer binding CD8 T cells. Furthermore, we showed that in spleen cells from RL male 1-bearing allogeneic B6 mice, H-2L(d)/pRL1a complex specific CD8 T cells were present at a significant frequency. H-2L(d)/pRL1a recognizing B6 CTL but not BALB/c or CB6F1 CTL gradually lost CD8 expression on their surface by multiplication of in vitro stimulation.
我们通过用RL雄性1肿瘤进行重复体外刺激,研究了在携带RL雄性1的同基因BALB/c、半同种异体CB6F1和同种异体B6小鼠的脾细胞中,识别与RL雄性1白血病上H-2L(d)分子结合的显性pRL1a肽的CD8细胞毒性T淋巴细胞(CTL)的产生。培养物中的CD8 T细胞也通过H-2L(d)/pRL1a四聚体染色进行分析。我们发现,与低反应性的BALB/c小鼠相比,在携带RL雄性1的高反应性CB6F1小鼠的脾细胞中能更有效地产生pRL1a特异性CTL,这与H-2L(d)/pRL1a四聚体结合CD8 T细胞的出现密切相关。此外,我们还发现,在携带RL雄性1的同种异体B6小鼠的脾细胞中,H-2L(d)/pRL1a复合物特异性CD8 T细胞以显著频率存在。识别H-2L(d)/pRL1a的B6 CTL,而不是BALB/c或CB6F1 CTL,通过体外刺激增殖会逐渐在其表面失去CD8表达。